Skip to content

Study of how guided bacterial therapy and regular oral hygiene help keep the gums healthy around dental implants that are loaded early

Evaluation of the effect of Guided Microbial Colonization (GMC) with structured home care on peri-implant health in early loaded dental implants: A prospective randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110186
Enrollment
34
Registered
2026-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Group A (n=17): Subjects with administration of Guided Microbial Colonization (GMC) at the time of implant placement, accompanied by structured home-care advocacy.: At baseline, patient

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants aged greater than 18 years will be included in the study. 2. Patients indicated for single-stage implant placement with early loading. 3. Adequate bone volume for implant placement without the need for augmentation 4. Willingness to participate and comply with follow-up visits

Exclusion criteria

Exclusion criteria: 1. Smokers or tobacco users. 2. Antibiotic or probiotic use within the last 3 months. 3. Pregnant or lactating women. 4. Known allergy to chlorhexidine or probiotic (Self-Reported). 5. Systemic diseases or conditions such as metabolic diseases, bone and haematological diseases, immunodeficiency, uncontrolled diabetes mellitus, kidney failure, tumor or radiation in the head and neck area or any other disease contraindicating implant placement. 6. Patients unwilling to complete the treatment protocol. 7. Patient with a history of allergic tendencies.

Design outcomes

Primary

MeasureTime frame
Microbial Metagenomic Analysis i.Relative abundance of microbiota ii.Microbial diversity iii.Dysbiosis index Clinical Evaluation including BOP, mPI, PD Patient-Reported Outcome Measures (PROMs) Timepoint: baseline,7 days,3 months and 6 months

Secondary

MeasureTime frame
Biochemical Parameters IL-1Beta,MMP 8 Radiographic Bone Levels Incidence of peri-implant mucositis Timepoint: baseline,7 days,3 months and 6 months

Countries

India

Contacts

Public ContactDr Gurparkash Singh Chahal

Dr Harvansh Singh Judge Institute of Dental Sciences and Hospital, Chandigarh

vishakha_grover@rediffmail.com9814277780

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026